Elanco Animal Health Incorporated vs Novartis AG
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Elanco Animal Health Incorporated currently has the stronger revenue growth signal.
Elanco Animal Health Incorporated and Novartis AG show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Elanco Animal Health Incorporated | Novartis AG |
|---|---|---|
| Current Price | ₹23.98 | ₹151.4 |
| Market Cap | ₹11,976.8 Cr. | ₹2.89 L Cr. |
| Industry | Pharmaceuticals | Pharmaceuticals |
| P/E Ratio | 18.812395 | 21.604586 |
| ROE (%) | — | — |
| Debt/Equity | — | — |
| Sales Growth 5Y (%) | — | — |
| Profit Growth 5Y (%) | — | — |
| Promoter Holding (%) | — | — |
| Revenue Rank | Rank 3 | Rank 4 |
| Margin Rank | Rank 1 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |
Analyze Elanco Animal Health Incorporated →Analyze Novartis AG →Compare other stocks →Stock Screener →
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.